Dr. Louis Jacques

Louis Jacques, M.D. is Chief Clinical Officer and a Senior Vice President at ADVI, where he is also a partner. He is a member of the EXCITE International Advisory Council.

ADVI is a health care advisory services firm with offices in Washington DC, Austin, and San Francisco.

Before joining ADVI in 2014, Dr. Jacques was the Director of the Coverage and Analysis Group (CAG) in the Centers for Medicare & Medicaid Services (CMS) from 2009 - 2014, where he managed Medicare fee for service coverage policy development on technologies as diverse as molecular diagnostic testing, advanced imaging, chemotherapeutics, wound care, and screening and preventive services. From 2004 – 2009 he was a division director within CAG.

Before joining CMS in 2003, he served as the Associate Dean for Curriculum at Georgetown University School of Medicine; where he also saw patients at the Lombardi Cancer Center in his practice of hospice and palliative medicine.

Dr. Jacques also made volunteer home visits for a hospice on Maryland’s Eastern Shore. While in active clinical practice he was a diplomate of both the American Board of Hospice and Palliative Medicine and the American Board of Family Medicine. He recertified his Family Medicine boards in 2013.

Louis Jacques, EXCITE International Advisory Council

Dr. Louis Jacques

M.D., Chief Clinical Officer and a Senior Vice President at ADVI

Louis earned his undergraduate degree in 1978 from Georgetown University and his MD in 1982 from the University of Maryland. After completing his residency in family practice he served in a National Health Service Corps assignment in a Waterloo Iowa community health clinic.

Before returning to the Washington DC area he worked in Detroit with the Henry Ford Medical Group and joined the faculty of the Wayne State University School of Medicine.

« Back to Advisory Council Leadership Team Executive Board

Work with us. EXCITE International can assist you in facilitating multi-jurisdictional clinical trials through its partnership with government, clinical experts, methodology centres and health system decision makers.